The Role of Apolipoprotein D in Neurodegenerative Disorders
Author Information
Author(s): Kolanek Agata, Cemaga Roman, Maciejczyk Mateusz
Primary Institution: Medical University of Bialystok
Hypothesis
Apolipoprotein D (ApoD) may serve as a specific and sensitive biomarker for neurodegenerative diseases.
Conclusion
Apolipoprotein D is a promising biomarker for diagnosing and managing neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis.
Supporting Evidence
- Apolipoprotein D levels are elevated in the cerebrospinal fluid of Alzheimer's disease patients.
- Increased ApoD expression correlates with disease severity in Parkinson's disease.
- ApoD may help in monitoring disease progression in multiple sclerosis.
Takeaway
Apolipoprotein D is a protein that can help doctors find out if someone has brain diseases like Alzheimer's or Parkinson's by looking at their blood or other fluids.
Methodology
This review summarizes studies indexed in PubMed, Scopus, and Web of Science databases regarding the role of ApoD in neurodegenerative disorders.
Potential Biases
Potential biases may arise from the variability in study designs and populations in the reviewed literature.
Limitations
The review is based on existing literature, which may have small sample sizes and varying methodologies.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website